Evidence map›Paper›PMID 39060226›Full record

ArticleNature communications2024

Genomic insights into the 2022-2023Vibrio cholerae outbreak in Malawi.

Chrispin Chaguza, Innocent Chibwe, David Chaima, Patrick Musicha, Latif Ndeketa, Watipaso Kasambara, Chimwemwe Mhango, Upendo L Mseka, Joseph Bitilinyu-Bangoh, Bernard Mvula and 19 more

Abstract read
In one paragraph

Article in Nature communications, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed.

  1. Review
  2. Article
  3. Genomic and epidemiological insights into a non-toxigenic Vibrio cholerae O1 Ogawa from an autochthonous case in Brazil.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Genome-wide investigation of outbreak-associatedFrontiers in microbiology · 2026
    Article
  13. Article
  14. Whole Genome Sequencing of Drug-ResistantPathogens (Basel, Switzerland) · 2025
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

29 authors.

Chrispin Chaguza *Department of Epidemiology of Microbial Diseases, Yale School of Public Health, Yale University, New Haven, CT, USA. chrispin.chaguza@yale.edu.ORCID 0000-0002-2108-1757
Innocent Chibwe *Public Health Institute of Malawi, Ministry of Health, Lilongwe, Malawi.ORCID 0000-0002-2252-0993
David ChaimaDepartment of Pathology, School of Medicine and Oral Health, Kamuzu University of Health Sciences, Blantyre, Malawi.
Patrick MusichaParasites and Microbes Programme, Wellcome Sanger Institute, Hinxton, UK.ORCID 0000-0001-7780-2173
Latif NdeketaDepartment of Clinical Infection, Microbiology and Immunology, Institute of Infection, Veterinary and Ecological Sciences, University of Liverpool, Liverpool, UK.
Watipaso KasambaraPublic Health Institute of Malawi, Ministry of Health, Lilongwe, Malawi.
Chimwemwe MhangoMalawi-Liverpool-Wellcome Research Programme, Blantyre, Malawi.
Upendo L MsekaMalawi-Liverpool-Wellcome Research Programme, Blantyre, Malawi.
Joseph Bitilinyu-BangohPublic Health Institute of Malawi, Ministry of Health, Lilongwe, Malawi.
Bernard MvulaPublic Health Institute of Malawi, Ministry of Health, Lilongwe, Malawi.
Wakisa KipandulaDepartment of Medical Laboratory Sciences, Faculty of Biomedical Sciences and Health profession, Kamuzu University of Health Sciences, Blantyre, Malawi.
Patrick BonongweMinistry of Health, Balaka District Hospital, Balaka, Machinga, Malawi.
Richard J MunthaliDepartment of Psychiatry, University of British Columbia, Vancouver, BC, Canada.ORCID 0000-0001-8492-7409
Selemani NgwiraPublic Health Institute of Malawi, Ministry of Health, Lilongwe, Malawi.
Chikondi A MwenderaDepartment of Clinical Infection, Microbiology and Immunology, Institute of Infection, Veterinary and Ecological Sciences, University of Liverpool, Liverpool, UK.
Akuzike Kalizang'omaNIHR Mucosal Pathogens Research Unit, Research Department of Infection, Division of Infection and Immunity, University College London, London, UK.
Kondwani C JamboMalawi-Liverpool-Wellcome Research Programme, Blantyre, Malawi.ORCID 0000-0002-3195-2210
Dzinkambani KambalamePublic Health Institute of Malawi, Ministry of Health, Lilongwe, Malawi.
Arox W Kamng'onaDepartment of Biomedical Sciences, School of Life Sciences and Allied Health Professions, Kamuzu University of Health Sciences, Blantyre, Malawi.ORCID 0000-0002-0841-7586
A Duncan SteeleDiarrhoeal Pathogens Research Unit, Sefako Makgatho Health Sciences University, Medunsa, 0204, Pretoria, South Africa.
Annie Chauma-MwalePublic Health Institute of Malawi, Ministry of Health, Lilongwe, Malawi.
Daniel HungerfordDepartment of Clinical Infection, Microbiology and Immunology, Institute of Infection, Veterinary and Ecological Sciences, University of Liverpool, Liverpool, UK.ORCID 0000-0002-9770-0163
Matthew KagoliPublic Health Institute of Malawi, Ministry of Health, Lilongwe, Malawi.
Martin M NyagaNext Generation Sequencing Unit and Division of Virology, Faculty of Health Sciences, University of the Free State, Bloemfontein, 9300, South Africa.ORCID 0000-0002-5017-5584
Queen DubeMalawi Ministry of Health, Lilongwe, Malawi.
Neil FrenchDepartment of Clinical Infection, Microbiology and Immunology, Institute of Infection, Veterinary and Ecological Sciences, University of Liverpool, Liverpool, UK.
Chisomo L MsefulaDepartment of Pathology, School of Medicine and Oral Health, Kamuzu University of Health Sciences, Blantyre, Malawi.
Nigel A CunliffeDepartment of Clinical Infection, Microbiology and Immunology, Institute of Infection, Veterinary and Ecological Sciences, University of Liverpool, Liverpool, UK.
Khuzwayo C JereDepartment of Clinical Infection, Microbiology and Immunology, Institute of Infection, Veterinary and Ecological Sciences, University of Liverpool, Liverpool, UK. Khuzwayo.Jere@liverpool.ac.uk.ORCID 0000-0003-3376-8529

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Malawi experienced its deadliest Vibrio cholerae (Vc) outbreak following devastating cyclones, with >58,000 cases and >1700 deaths reported between March 2022 and May 2023. Here, we use population genomics to investigate the attributes and origin of the Malawi 2022-2023 Vc outbreak isolates. Our results demonstrate the predominance of ST69 clone, also known as the seventh cholera pandemic El Tor (7PET) lineage, expressing O1 Ogawa (~ 80%) serotype followed by Inaba (~ 16%) and sporadic non-O1/non-7PET serogroups (~ 4%). Phylogenetic reconstruction revealed that the Malawi outbreak strains correspond to a recent importation from Asia into Africa (sublineage AFR15). These isolates harboured known antimicrobial resistance and virulence elements, notably the ICE

Indexed as

CholeraDisease OutbreaksPhylogenyVibrio choleraeGenome, BacterialGenomicsGenotypeHumansMalawiProphagesSerogroup

Identifiers

PMID39060226
PMCPMC11282309

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.